S

Supernus Pharmaceuticals

D
SUPN
USD
-1.365
(-3.6159%)
Market Closed
16,738.00
Volume
1.09
EPS
-
Div Yield
404.28
P/E
2,005,009,506.00
Market Cap
Today
1.5206%
1 Week
6.732%
1 Month
13.668%
6 Months
16.806%
12 Months
52.494%
Year To Date
25.856%
All Time
0%

Title:
Supernus Pharmaceuticals

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia inPD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Do you need help or have a question?